2015
Endocrinologicalapproach to the diagnosis of pancreatic neuroendocrine neoplasms
Publication
Publication
n patients with so-called functioning or syndromic pancreatic neuroendocrine tumors (PanNETs), specific biochemical tests should be requested in blood or 24-h urine samples obtained with or without provocative testing. Levels of circulating markers or urinary excreted products can be monitored and used for tumor follow-up. These tumors include gastrinomas, insulinomas, VIPomas, glucagonomas, GHRHomas, ACTHomas, PTHrPomas, somatostatinomas, PanNETs causing the carcinoid syndrome, and PanNETs secreting cholecystokinin (CCK), insulinlike growth factor II (IGF-II), renin, luteinizing hormone (LH), and erythropoietin
| Additional Metadata | |
|---|---|
| doi.org/10.1007/978-3-319-17235-4_4, hdl.handle.net/1765/86656 | |
| Organisation | Department of Internal Medicine |
|
de Herder, W. (2015). Endocrinologicalapproach to the diagnosis of pancreatic neuroendocrine neoplasms. doi:10.1007/978-3-319-17235-4_4 |
|